Skip to main content

Table 1 Summary of included studies. Trial length, number of patients, blood pressure and demographic data pooled from the included studies

From: Healthcare professional-led interventions on lifestyle modifications for hypertensive patients – a systematic review and meta-analysis

 

Study design

Country

Trial length in month

Number of patients included

Proportion of patients under BP control %

Diastolic BP at recruitment, mmHg

Systolic BP at recruitment, mmHg

Patients with diabetes %

Female %

Mean age

Race

Proportion using antihypertensive medication, %

Artinian 2007

RCT

USA

8

387

0

> = 90

> = 140

25.83

64.34

59.65

100% African Americans

70.54

Borenstein 2003

RCT

USA

12

197

0

> = 90

> = 140

13

61

62

32% African Americans

N/A

Bosworth 2009

RCT

USA

24

636

73

di

di

36

66

61

49% African Americans

100

Bosworth 2011

RCT

USA

18

591

59

> 90

> 140

43

8

64

48% white

100

Brennan 2010

RCT

USA

12

638

14

di

di

26

67

55.7

100% African Americans

96

Garcia-Pena 2001

RCT

Mexico

6

718

0

> = 90

> = 160

26

64

70.6

N/A

77

Green 2008

RCT

USA

12

778

0

90–109

140–199

N/A

52.2

59.1

82,8% white

96

Hennessy 2006

cRCT

USA

6

10,696

53.29

di

di

25.48

56.95

62.3

48% Caucasian

66.77

Hunt 2004

RCT

USA

12

604

0

90–99

140–159

15

58

69

90% white

N/A

Hunt 2008

RCT

USA

12

463

0

> = 100

> = 160

25

65

68

N/A

N/A

Johnson 2011

RCT

USA

6

552

0

di

di

43

65

42

91% African Americans

96

Kastarinen 2002

RCT

Finland

24

715

N/A

90–109

140–179

N/A

53

54.3

N/A

52

Lang 1995

cRCT

France

18

129

0

> 90

> 140

N/A

5

43

N/A

19

Lee 2007

RCT

Taiwan

6

202

0

N/A

140–179

N/A

42

71.3

N/A

68

Little 2004

cRCT

USA

1

296

0

> 90

> 160

N/A

44

50

N/A

0

Ma 2014

RCT

China

6

120

N/A

di

di

N/A

50.83

58.76

N/A

100

Magid 2011

RCT

USA

6

338

0

> 90 (80a)

> 140 (130a)

54

35

65.4

65% white

100

Margolis 2013

cRCT

USA

18

450

0

> = 90

> = 140

19.11

44.7

61.1

81.8 white

73.8

McKenney 1973

RCT

USA

5

50

32

> 90

N/A

N/A

76

60

78% African American

N/A

McLean 2008

RCT

Canada

6

227

3

> 80

> 130

100

40

64.95

N/A

66.95

Mehos 2000

RCT

USA

6

36

0

90–109

140–179

19.44

69.44

58.8

77.77 Caucasian

100

Morgado 2011

RCT

Portugal

9

197

33

di

di

18

60

59.5

N/A

100

Roumie 2006

cRCT

USA

6

1827

0

> = 90

> 140

4.02

3

65

N/A

100

Saleem 2015

RCT

Pakistan

9

385

41.8

di

di

N/A

31.2

39

N/A

100

Sookaneknun 2004

RCT

Thailand

6

235

20.42

> = 90

> = 140

44

68

63.2

N/A

N/A

Stewart 2005

RCT

South Africa

6

83

N/A

di

di

N/A

N/A

N/A

N/A

N/A

Tobari 2010

RCT

Japan

6

132

38.63

90–109

140–179

N/A

34

61.65

N/A

94

Tonstad 2007

RCT

Norway

6

49

0

90–99

140–169

N/A

26.53

55

N/A

16.32

Vivian 2002

RCT

USA

6

56

0

> 90

> 140

51

0

64.75

77.4% African American

100

Wakefield 2011

RCT

USA

6

302

N/A

di

di

100

2

68

96% Caucasian

N/A

Wal 2013

RCT

India

6

142

0

> 90

> 140

40.19

55.88

60.06

N/A

N/A

Woollard 1995

RCT

Australia

4.5

166

N/A

di

di

N/A

46.57

58.3

N/A

100

Zabler 2018

RCT

China

6

59

N/A

di

di

N/A

63

53.73

100% African American

100

Zhu 2017

RCT

USA

4

134

0

> = 90

> 140

23.9

50.7

69

N/A

81

Zillich 2005

cRCT

USA

3

125

0

di

di

28

61

65

97.6% white

100

  1. di - inclusion under diagnoses of hypertension, the range of inclusion BP not specified
  2. N/A data not available
  3. a different inclusion blood pressure for diabetes patients